Journal article · 2022 · Open access
Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews
Journal of Patient-Reported Outcomes, 6(1), 60 · Published 3 June 2022 · DOI 10.1186/s41687-022-00460-z
In brief
“Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews” is a 2022 journal article by Carla DeMuro and 4 co-authors, published in Journal of Patient-Reported Outcomes. OpenAlex counts 8 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Patient-Reported Outcomes.
- Citations
- 8
- Most cited in
- 2024 (3)
- Field-weighted impact
- 0.50
- References
- 23
- Authors
- 5
Abstract
BACKGROUND: Patient-reported outcome (PRO) measures are critical for assessing treatment benefit of anticancer treatments. Although PRO measures have been developed with the intention of capturing patient-centric concepts, a gap exists in understanding the patient experience with these tools. We characterized the experience of patients with metastatic breast cancer (mBC) with PRO measures in an oncology clinical trial setting to determine the importance, relevance, barriers, and facilitators for PRO completion. METHODS: The multicenter, qualitative design included semistructured interviews with 18 women with mBC who completed PRO measures in a clinical trial setting within 1 year of screening. Interviews began with concept elicitation to understand symptom characterization, decision to participate in a clinical trial, pre-trial expectations, and thoughts on study-related questionnaires. Cognitive debriefing was conducted to determine if items in a commonly used PRO instrument were relevant to the patient experience. Qualitative data were analyzed using a constant comparative approach. RESULTS: Participants described the need for detailed explanation of PRO measures at study start, including information about how the PRO data will likely be used to support drug development. Respondents who felt connected to clinical trial research were more likely to feel as if the measures adequately captured their experiences. Items that were deemed irrelevant or out of date to the patient experience may cause a respondent to feel marginalized and adds to the overall burden of PRO measure completion. Mode of PRO measure administration (electronic/paper) was important to some, but placement of the instrument completion within a study visit appeared to influence respondent willingness to fully engage with the measures. A lack of any type of feedback loop to allow respondents to learn from the captured PRO data was noted as important but missing from the patient experience. CONCLUSIONS: PRO measures need to include content that is relevant to the patient experience over the course of the clinical trial period to be considered meaningful to respondents, and administration techniques also impact engagement. Robust communication strategies that socialize the intent, use, and results of PRO data may enrich the patient experience and support greater adherence to PRO completion in future studies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
DeMuro, C., Harris, N., Gnanasakthy, A., D’Alessio, D., & Chandiwana, D. (2022). Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews. Journal of Patient-Reported Outcomes, 6(1), 60. https://doi.org/10.1186/s41687-022-00460-z
MLA 9
DeMuro, Carla, et al. “Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews.” Journal of Patient-Reported Outcomes, vol. 6, no. 1, 2022, p. 60. https://doi.org/10.1186/s41687-022-00460-z.
Chicago
DeMuro, Carla, Nimanee Harris, Ari Gnanasakthy, Denise D’Alessio, and David Chandiwana. 2022. “Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews.” Journal of Patient-Reported Outcomes 6 (1): 60. https://doi.org/10.1186/s41687-022-00460-z.
Harvard
DeMuro, C. et al. (2022) ‘Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews’, Journal of Patient-Reported Outcomes, 6(1), p. 60. doi:10.1186/s41687-022-00460-z.
IEEE
C. DeMuro, N. Harris, A. Gnanasakthy, D. D’Alessio, and D. Chandiwana, “Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews,” Journal of Patient-Reported Outcomes, vol. 6, no. 1, p. 60, 2022, doi: 10.1186/s41687-022-00460-z.
BibTeX
@article{demuro2022patient,
title = {{Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews}},
author = {DeMuro, Carla and Harris, Nimanee and Gnanasakthy, Ari and D’Alessio, Denise and Chandiwana, David},
journal = {Journal of Patient-Reported Outcomes},
year = {2022},
volume = {6},
number = {1},
pages = {60},
doi = {10.1186/s41687-022-00460-z},
url = {https://doi.org/10.1186/s41687-022-00460-z}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 1 | |
| 2023 | 1 | |
| 2024 | 3 | |
| 2026 | 3 |
Its field-weighted citation impact is 0.50: it has been cited 0.50 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- patient-reported outcome measures
- metastatic breast cancer
- patient experience
- clinical trial participation
- cognitive debriefing
- mode of administration
- patient engagement
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
DeMuro, C., Harris, N., Gnanasakthy, A., D’Alessio, D., & Chandiwana, D. (2022). Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews. Journal of Patient-Reported Outcomes, 6(1), 60. https://doi.org/10.1186/s41687-022-00460-z
How many times has this paper been cited?
8 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Patient-Reported Outcomes: sign in and open the PDF from this page.
Who wrote this paper?
Carla DeMuro, Nimanee Harris, Ari Gnanasakthy, Denise D’Alessio, David Chandiwana.
What is the DOI of this paper?
10.1186/s41687-022-00460-z, permanently at https://doi.org/10.1186/s41687-022-00460-z. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.